N-(3-acyloxy-2-benzylpropyl)-N′-(4-hydroxy-3-methoxybenzyl)thiourea derivatives as potent vanilloid receptor agonists and analgesics

Jeewoo Lee, Jiyoun Lee, Jiyoung Kim, Soo Yeon Kim, Moon Woo Chun, Hawon Cho, Sun Wook Hwang, Uhtaek Oh, Young Ho Park, Victor E. Marquez, Maryam Beheshti, Tamas Szabo, Peter M. Blumberg

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

A series of N-(3-acyloxy-2-benzylpropyl)-N′-(4-hydroxy-3-methoxybenzyl)thiourea derivatives were investigated as vanilloid receptor ligands in an effort to discover a novel class of analgesics. The proposed pharmacophore model of resiniferatoxin, which includes the C20-homovanillic moiety, the C3-carbonyl and the orthoester phenyl ring as key pharmacophoric groups, was utilized as a guide for drug design. The compounds were synthesized after several steps from diethylmalonate and evaluated in vitro in a receptor binding assay and in a capsaicin-activated channel assay. Additional evaluation of analgesic activity, anti-inflammatory activity and pungency was conducted in animal models by the writhing test, the ear edema assay, and the eye-wiping test, respectively. Among the new compounds, 23 and 28 were found to be the most potent receptor agonists of the series with Ki values of 19 nM and 11 nM, respectively. Their strong in vitro potencies were also reflected by an excellent analgesic profile in animal tests with ED50 values of 0.5 μg/kg for 23 and 1.0 μg/kg for 28. Relative to capsaicin these compounds appear to be ca. 600 and 300 times more potent. Both 23 and 28 were found to be less pungent than capsaicin based on the eye-wiping test. However, the compounds did not show significant anti-inflammatory activity. A molecular modeling study comparing the energy-minimized structures of resiniferatoxin and 35 demonstrated a good correlation in the spatial disposition of the corresponding key pharmacophores. The thioureas described in this investigation, which were designed as simplified resiniferatoxin surrogates, represent a novel class of potent vanilloid receptor agonists endowed with potent analgesic activity and reduced pungency.

Original languageEnglish
Pages (from-to)19-32
Number of pages14
JournalBioorganic and Medicinal Chemistry
Volume9
Issue number1
DOIs
Publication statusPublished - 2001 Jan 8
Externally publishedYes

Fingerprint

TRPV Cation Channels
Thiourea
Capsaicin
Analgesics
Derivatives
Assays
Animals
Anti-Inflammatory Agents
Drug Design
Non-Steroidal Anti-Inflammatory Agents
Molecular modeling
Ear
Edema
Animal Models
Ligands
resiniferatoxin
Pharmaceutical Preparations
In Vitro Techniques

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

N-(3-acyloxy-2-benzylpropyl)-N′-(4-hydroxy-3-methoxybenzyl)thiourea derivatives as potent vanilloid receptor agonists and analgesics. / Lee, Jeewoo; Lee, Jiyoun; Kim, Jiyoung; Kim, Soo Yeon; Chun, Moon Woo; Cho, Hawon; Hwang, Sun Wook; Oh, Uhtaek; Park, Young Ho; Marquez, Victor E.; Beheshti, Maryam; Szabo, Tamas; Blumberg, Peter M.

In: Bioorganic and Medicinal Chemistry, Vol. 9, No. 1, 08.01.2001, p. 19-32.

Research output: Contribution to journalArticle

Lee, J, Lee, J, Kim, J, Kim, SY, Chun, MW, Cho, H, Hwang, SW, Oh, U, Park, YH, Marquez, VE, Beheshti, M, Szabo, T & Blumberg, PM 2001, 'N-(3-acyloxy-2-benzylpropyl)-N′-(4-hydroxy-3-methoxybenzyl)thiourea derivatives as potent vanilloid receptor agonists and analgesics', Bioorganic and Medicinal Chemistry, vol. 9, no. 1, pp. 19-32. https://doi.org/10.1016/S0968-0896(00)00216-9
Lee, Jeewoo ; Lee, Jiyoun ; Kim, Jiyoung ; Kim, Soo Yeon ; Chun, Moon Woo ; Cho, Hawon ; Hwang, Sun Wook ; Oh, Uhtaek ; Park, Young Ho ; Marquez, Victor E. ; Beheshti, Maryam ; Szabo, Tamas ; Blumberg, Peter M. / N-(3-acyloxy-2-benzylpropyl)-N′-(4-hydroxy-3-methoxybenzyl)thiourea derivatives as potent vanilloid receptor agonists and analgesics. In: Bioorganic and Medicinal Chemistry. 2001 ; Vol. 9, No. 1. pp. 19-32.
@article{b50cf7eeaae94010bb49dad0e45e3fc9,
title = "N-(3-acyloxy-2-benzylpropyl)-N′-(4-hydroxy-3-methoxybenzyl)thiourea derivatives as potent vanilloid receptor agonists and analgesics",
abstract = "A series of N-(3-acyloxy-2-benzylpropyl)-N′-(4-hydroxy-3-methoxybenzyl)thiourea derivatives were investigated as vanilloid receptor ligands in an effort to discover a novel class of analgesics. The proposed pharmacophore model of resiniferatoxin, which includes the C20-homovanillic moiety, the C3-carbonyl and the orthoester phenyl ring as key pharmacophoric groups, was utilized as a guide for drug design. The compounds were synthesized after several steps from diethylmalonate and evaluated in vitro in a receptor binding assay and in a capsaicin-activated channel assay. Additional evaluation of analgesic activity, anti-inflammatory activity and pungency was conducted in animal models by the writhing test, the ear edema assay, and the eye-wiping test, respectively. Among the new compounds, 23 and 28 were found to be the most potent receptor agonists of the series with Ki values of 19 nM and 11 nM, respectively. Their strong in vitro potencies were also reflected by an excellent analgesic profile in animal tests with ED50 values of 0.5 μg/kg for 23 and 1.0 μg/kg for 28. Relative to capsaicin these compounds appear to be ca. 600 and 300 times more potent. Both 23 and 28 were found to be less pungent than capsaicin based on the eye-wiping test. However, the compounds did not show significant anti-inflammatory activity. A molecular modeling study comparing the energy-minimized structures of resiniferatoxin and 35 demonstrated a good correlation in the spatial disposition of the corresponding key pharmacophores. The thioureas described in this investigation, which were designed as simplified resiniferatoxin surrogates, represent a novel class of potent vanilloid receptor agonists endowed with potent analgesic activity and reduced pungency.",
author = "Jeewoo Lee and Jiyoun Lee and Jiyoung Kim and Kim, {Soo Yeon} and Chun, {Moon Woo} and Hawon Cho and Hwang, {Sun Wook} and Uhtaek Oh and Park, {Young Ho} and Marquez, {Victor E.} and Maryam Beheshti and Tamas Szabo and Blumberg, {Peter M.}",
year = "2001",
month = "1",
day = "8",
doi = "10.1016/S0968-0896(00)00216-9",
language = "English",
volume = "9",
pages = "19--32",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - N-(3-acyloxy-2-benzylpropyl)-N′-(4-hydroxy-3-methoxybenzyl)thiourea derivatives as potent vanilloid receptor agonists and analgesics

AU - Lee, Jeewoo

AU - Lee, Jiyoun

AU - Kim, Jiyoung

AU - Kim, Soo Yeon

AU - Chun, Moon Woo

AU - Cho, Hawon

AU - Hwang, Sun Wook

AU - Oh, Uhtaek

AU - Park, Young Ho

AU - Marquez, Victor E.

AU - Beheshti, Maryam

AU - Szabo, Tamas

AU - Blumberg, Peter M.

PY - 2001/1/8

Y1 - 2001/1/8

N2 - A series of N-(3-acyloxy-2-benzylpropyl)-N′-(4-hydroxy-3-methoxybenzyl)thiourea derivatives were investigated as vanilloid receptor ligands in an effort to discover a novel class of analgesics. The proposed pharmacophore model of resiniferatoxin, which includes the C20-homovanillic moiety, the C3-carbonyl and the orthoester phenyl ring as key pharmacophoric groups, was utilized as a guide for drug design. The compounds were synthesized after several steps from diethylmalonate and evaluated in vitro in a receptor binding assay and in a capsaicin-activated channel assay. Additional evaluation of analgesic activity, anti-inflammatory activity and pungency was conducted in animal models by the writhing test, the ear edema assay, and the eye-wiping test, respectively. Among the new compounds, 23 and 28 were found to be the most potent receptor agonists of the series with Ki values of 19 nM and 11 nM, respectively. Their strong in vitro potencies were also reflected by an excellent analgesic profile in animal tests with ED50 values of 0.5 μg/kg for 23 and 1.0 μg/kg for 28. Relative to capsaicin these compounds appear to be ca. 600 and 300 times more potent. Both 23 and 28 were found to be less pungent than capsaicin based on the eye-wiping test. However, the compounds did not show significant anti-inflammatory activity. A molecular modeling study comparing the energy-minimized structures of resiniferatoxin and 35 demonstrated a good correlation in the spatial disposition of the corresponding key pharmacophores. The thioureas described in this investigation, which were designed as simplified resiniferatoxin surrogates, represent a novel class of potent vanilloid receptor agonists endowed with potent analgesic activity and reduced pungency.

AB - A series of N-(3-acyloxy-2-benzylpropyl)-N′-(4-hydroxy-3-methoxybenzyl)thiourea derivatives were investigated as vanilloid receptor ligands in an effort to discover a novel class of analgesics. The proposed pharmacophore model of resiniferatoxin, which includes the C20-homovanillic moiety, the C3-carbonyl and the orthoester phenyl ring as key pharmacophoric groups, was utilized as a guide for drug design. The compounds were synthesized after several steps from diethylmalonate and evaluated in vitro in a receptor binding assay and in a capsaicin-activated channel assay. Additional evaluation of analgesic activity, anti-inflammatory activity and pungency was conducted in animal models by the writhing test, the ear edema assay, and the eye-wiping test, respectively. Among the new compounds, 23 and 28 were found to be the most potent receptor agonists of the series with Ki values of 19 nM and 11 nM, respectively. Their strong in vitro potencies were also reflected by an excellent analgesic profile in animal tests with ED50 values of 0.5 μg/kg for 23 and 1.0 μg/kg for 28. Relative to capsaicin these compounds appear to be ca. 600 and 300 times more potent. Both 23 and 28 were found to be less pungent than capsaicin based on the eye-wiping test. However, the compounds did not show significant anti-inflammatory activity. A molecular modeling study comparing the energy-minimized structures of resiniferatoxin and 35 demonstrated a good correlation in the spatial disposition of the corresponding key pharmacophores. The thioureas described in this investigation, which were designed as simplified resiniferatoxin surrogates, represent a novel class of potent vanilloid receptor agonists endowed with potent analgesic activity and reduced pungency.

UR - http://www.scopus.com/inward/record.url?scp=0035192117&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035192117&partnerID=8YFLogxK

U2 - 10.1016/S0968-0896(00)00216-9

DO - 10.1016/S0968-0896(00)00216-9

M3 - Article

VL - 9

SP - 19

EP - 32

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 1

ER -